Background. Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor
type-1 (PAI-1) play a key role in tumour invasion and metastasis. High levels of both …

Background: The natural course of traditionally prognostically unfavorable human epidermal
growth factor receptor 2 (HER2)-positive breast cancer has been changed by anti-HER2 …

Background: Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor-1
(PAI-1) are important prognostic biomarkers for poor response, especially in patients with …

Background: Postmenopausal bleeding (PMB) is a common cause of gynecologic
exploration. Endometrial carcinoma (EC) is the most serious lesion to find. Until recently …

Introduction/Background Currently available imaging techniques are often inadequate for
early breast cancer detection, hence the interest for novel non-invasive biologic markers …

Objective: To evaluate the detection methods and management of recurrence in stage I
epithelial ovarian carcinoma. Methods: We investigated detection methods, patterns of …

Introduction/Background Triple negative breast cancer (TNBC) is characterized by worse
prognosis compared to other breast cancer subtypes. However due to different molecular …

Aim: Today diagnosis of breast cancer is earlier. There are sizable proportion of women with
breast cancer in earlier stage with tumours smaller in diameter and negative axillary lymph …

Aim: The aim of our study was to establish the number of local recurences of breast cancer
carcinoma, primarily treated in our institution. Methods: The retrospective analysis included …